Editorial: The Different Facets of Diabetes, Dyslipidemia and Hypertension in Cardio-metabolic Diseases: Current Perspective and Future Developments

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|23|10|1425-1426

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.23, Iss.10, 2017-05, pp. : 1425-1426

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Editorial (Thematic Issue: Cardio-Metabolic Complications: Current Perspective and Future Developments)

By  

Current Pharmaceutical Design, Vol. 20, Iss. 9, 2014-03 ,pp. : 1303-1304

Bentham Science Publishers

Access to resources Recommend Favorite

Hormonal Regulation of Nitric Oxide (NO) in Cardio-metabolic Diseases

By  

Current Pharmaceutical Design, Vol. 23, Iss. 10, 2017-05 ,pp. : 1427-1434

Bentham Science Publishers

Access to resources Recommend Favorite

Progranulin, a New Adipokine at the Crossroads of Metabolic Syndrome, Diabetes, Dyslipidemia and Hypertension

By  

Current Pharmaceutical Design, Vol. 23, Iss. 10, 2017-05 ,pp. : 1533-1539

Bentham Science Publishers

Access to resources Recommend Favorite

Regulation of Na+/K+-ATPase by Estradiol and IGF-1 in Cardio-Metabolic Diseases

By  

Current Pharmaceutical Design, Vol. 23, Iss. 10, 2017-05 ,pp. : 1551-1561

Bentham Science Publishers

Access to resources Recommend Favorite

Editorial (Recent Developments and Future Directions at Current Computer Aided Drug Design)

By  

Current Computer - Aided Drug Design, Vol. 9, Iss. 1, 2013-03 ,pp. : 1-1

Bentham Science Publishers

Access to resources Recommend Favorite